Pharmafile Logo
Pharmafocus logo
Advanced Search
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

July 1, 2020
Research and Development COVID-19, coronavirus

COVID-19 vaccines dominate this week’s news cycle, with Vaxart announcing the selection of its lead candidate for COVID-19 by Operation …

News
vacinnenenen

US buys most of the world’s stock of COVID-19 drug remdesivir

July 1, 2020
Research and Development COVID-19, coronavirus

The US has bought most of the world’s stock of the drug remdesivir which is one of the only drugs …

News
fda

FDA says COVID-19 vaccine would need to be at least 50% effective to be approved

July 1, 2020
Research and Development COVID-19, FDA, coronavirus

The FDA announced that any COVID-19 vaccine that gets approval must show that it is at least 50% more effective …

News
vaccinessssssssssssssssssss

India to go ahead with human trials of COVID-19 vaccine in July

June 30, 2020
Manufacturing and Production COVID-19, Vaccine, coronavirus

A trial of a new Indian made vaccine will begin testing in humans from July. The vaccine is called Covaxin …

News
roche

Roche’s Phesgo combo secures US approval for metastatic HER2-positive breast cancer

June 30, 2020
Manufacturing and Production, Sales and Marketing FDA, Phesgo, Roche, US, breast cancer

The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …

News

New swine flu with pandemic potential identified in China

June 30, 2020
Manufacturing and Production flu, flu pandemic, swine flu

A new strain of flu has emerged in pigs in China, with scientists warning it has pandemic potential. Researchers call …

News
pharmafocus_july-august_2020_cover

The July/August 2020 issue of Pharmafocus is available to read free online now!

June 30, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Pharmafocus, pharma

The July/August 2020 issue of Pharmafocus is available to read free online now!

News
remsss

Gilead facing criticism for charging $2,340 for remdesivir

June 30, 2020
Manufacturing and Production COVID-19, coronavirus

Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has …

News

NICE knocks back Janssen’s Zytiga combo for newly diagnosed, hormone-sensitive metastatic prostate cancer.

June 29, 2020
Sales and Marketing

Drug watchdog NICE has chosen to stick with its earlier decision not to recommend Janssen’s Zytiga (abiraterone aetate), combined with …

News
fdaoutsideweb

FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns

June 29, 2020
Sales and Marketing AbbVie, Allergan, FDA, pharma

The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …

News

Vaxart announces its COVID-19 vaccine has been selected by US Operation Warp Speed programme

June 29, 2020
Sales and Marketing COVID-19, COVID-19 vaccine, coronavirus, coronavirus vaccine

Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …

News
chinese_army

China’s COVID-19 vaccine candidate approved for military use

June 29, 2020
Sales and Marketing COVID-19, coronavirus

China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe …

News
Pfizer headquarters

Pfizer sues US for permission to help Medicare patients with rare heart conditions

June 29, 2020
Sales and Marketing Medicaid, Medicare, Pfizer

Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare …

News
nhs_hispioiotror

NICE to recommend Roche cancer treatment

June 26, 2020
Medical Communications NHS, NICE

NICE are set to recommend Roche’s Rozlytrek (Entrectinib) cancer treatment which will be the second histology drug to be recommended …

News

Novartis agrees to pay $347 million to settle bribery allegations

June 26, 2020
Medical Communications Greece, Novartis, bribery

Novartis and its former eye care unit Alcon have agreed to pay a combined $347 million to resolve allegations that …

News
boots

70% of BAME pharmacists in the UK have had no risk assessment for COVID-19

June 26, 2020
Medical Communications COVID-19, coronavirus

More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, …

News
remdesivir_ulrich_perrey

Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19

June 26, 2020
Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir

In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …

News
top_10_image_2_2

Top Ten most popular articles on Pharmafile.com this week

June 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …

News
shutterstock_2

AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership

June 25, 2020
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …

News

NICE knocks back Novartis’ Mayzent in secondary progressive multiple sclerosis over data gaps

June 25, 2020
Sales and Marketing Mayzent, NHS, NICE, Novartis

Novartis’ Mayzent (siponimod) has been unsuccessful in securing a recommendation from NICE for use on the NHS for the treatment …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026